What is the role of apheresis technology in stem cell transplantation?

被引：1

作者：

Kiki, Ilhami ^{[1
]}

机构：

[1] Ataturk Univ, Sch Med, Div Hematol, Dept Internal Med, Erzurum, Turkey

来源：

TRANSFUSION AND APHERESIS SCIENCE | 2017年 / 56卷 / 06期

关键词：

Apheresis Technology; Stem Cell Transplantation; Autologous; Allogeneic; COLONY-STIMULATING FACTOR; HEMATOPOIETIC PROGENITOR CELLS; VERSUS-HOST-DISEASE; BONE-MARROW TRANSPLANTATION; LETHALLY IRRADIATED DOGS; PERIPHERAL-BLOOD; AUTOLOGOUS TRANSPLANTATION; EXTRACORPOREAL PHOTOCHEMOTHERAPY; MULTIPLE-MYELOMA; IMMUNE HEMOLYSIS;

D O I：

10.1016/j.transci.2017.11.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Since the demonstration that hematopoietic cells are present in circulating blood, peripheral blood stem cell transplantation (PBSCT) has become an area of interest. The invention-of growth factors such as the granulocyte colony-stimulating factor (G-CSF) and the availability of apheresis techniques allowed the wide application of peripheral blood stem cells (PBSC) in both autologous and allogeneic hematopoietic stem cell transplantation settings. It has been since 1986 that clinically introduced, peripheral blood stem cells replaced bone marrow as a stem-cell source to nearly 100% in the autologous and to approximately 75% in the allogeneic transplantation setting. During this period of time, remarkable development occurred in both stem cell mobilizing agents (i.e. CXCR4 antagonists) and apheresis techniques. Currently, apheresis technology is being increasingly used in not only for collection of PBSC or blood product support, but also for treatment and/or prevention of several transplantations related complications. Apheresis technology also allows to manipulate stem cells and thus provides opportunity to curative treatment of certain diseases. (C) 2017 Elsevier Ltd. All rights reserved.

引用

页码：788 / 794

页数：7

共 74 条

[1] Prospective randomised comparison of the COBE Spectra version 6 and haemonetics MCS plus cell separators for hematopoietic progenitor cells leucapheresis in patients with multiple myeloma [J].

Abdelkefi, A. ;

Maamar, M. ;

Torjman, L. ;

Ladeb, S. ;

Lakhal, A. ;

Ben Othman, T. ;

Slama, H. ;

Jenhani, F. ;

Mojaat, N. ;

Ben Hamed, L. ;

Bouhoula, S. ;

Hsairi, M. ;

Boukef, K. ;

Ben Abdeladhim, A. .

JOURNAL OF CLINICAL APHERESIS, 2006, 21 (02) :111-115

[2]

ABRAMS RA, 1980, BLOOD, V56, P516

[3]

[Anonymous], 2016, MECH TREATMENT GRAFT

[4] Controlled study of citrate effects and response to IV calcium administration during allogeneic peripheral blood progenitor cell donation [J].

Bolan, CD ;

Cecco, SA ;

Wesley, RA ;

Horne, M ;

Yau, YY ;

Remaley, AT ;

Childs, RW ;

Barrett, AJ ;

Rehak, NN ;

Leitman, SF .

TRANSFUSION, 2002, 42 (07) :935-946

[5] Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility [J].

Bolan, CD ;

Childs, RW ;

Procter, JL ;

Barrett, AJ ;

Leitman, SF .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) :787-795

[6] Clinical Guide to ASO-Incompatible Allogeneic Stem Cell Transplantation [J].

Booth, Garrett S. ;

Gehrie, Eric A. ;

Bolan, Charles D. ;

Savani, Bipin N. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (08) :1152-1158

[7] Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease [J].

Brudno, Jennifer N. ;

Somerville, Robert P. T. ;

Shi, Victoria ;

Rose, Jeremy J. ;

Halverson, David C. ;

Fowler, Daniel H. ;

Gea-Banacloche, Juan C. ;

Pavletic, Steven Z. ;

Hickstein, Dennis D. ;

Lu, Tangying L. ;

Feldman, Steven A. ;

Iwamoto, Alexander T. ;

Kurlander, Roger ;

Maric, Irina ;

Goy, Andre ;

Hansen, Brenna G. ;

Wilder, Jennifer S. ;

Blacklock-Schuver, Bazetta ;

Hakim, Frances T. ;

Rosenberg, Steven A. ;

Gress, Ronald E. ;

Kochenderfer, James N. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) :1112-+

[8] Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers [J].

Carlo-Stella, C ;

Di Nicola, M ;

Milani, R ;

Guidetti, A ;

Magni, M ;

Milanesi, M ;

Longoni, P ;

Matteucci, P ;

Formelli, F ;

Ravagnani, F ;

Corradini, P ;

Gianni, AM .

BLOOD, 2004, 103 (09) :3287-3295

[9] Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy [J].

Cavallo, F. ;

Bringhen, S. ;

Milone, G. ;

Ben-Yehuda, D. ;

Nagler, A. ;

Calabrese, E. ;

Cascavilla, N. ;

Montefusco, V. ;

Lupo, B. ;

Liberati, A. M. ;

Crippa, C. ;

Rossini, F. ;

Passera, R. ;

Patriarca, F. ;

Cafro, A. M. ;

Omede, P. ;

Carella, A. M. ;

Peccatori, J. ;

Catalano, L. ;

Caravita, T. ;

Musto, P. ;

Petrucci, M. T. ;

Boccadoro, M. ;

Palumbo, A. .

LEUKEMIA, 2011, 25 (10) :1627-1631

[10] RECOVERY OF LETHALLY IRRADIATED DOGS GIVEN INFUSIONS OF AUTOLOGOUS LEUKOCYTES PRESERVED AT -80 C [J].

CAVINS, JA ;

FERREBEE, JW ;

SCHEER, SC ;

THOMAS, ED .

BLOOD, 1964, 23 (01) :38-&

← 1 2 3 4 5 6 7 8 →